Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
7
×
life sciences
national blog main
boston top stories
indiana blog main
indiana top stories
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
eli lilly
fda
ipo
sanofi
bristol-myers squibb
clinical trials
deals
drug prices
medicare
novartis
pfizer
startups
What
pharmaceutical
7
×
bio
roundup
drug
cancer
drugs
eli
giant
new
prices
typically
acute
addresses
alzheimer’s
american
appetite
approval
away
bails
based
best
black
brand
bread
bridgebio
bringing
butter
buyout
cancer’s
capital
car
cash
causes
ceos
companies
condition
continue
crash
dc
debate
Language
unset
Current search:
pharmaceutical
×
" boston blog main "
×
biotech
×
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More